Position in LLY
as of Jun 30, 2026
· filed Aug 19, 2026
Position Value
$98,452,820
+$29,036,859 QoQ
Shares Held
82,083
+8.8% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
2.77%
of 13F equity value
Holder Rank
#383
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 9%
Shared 0%
None 91%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2020CallValue
$15,802
CallShares
400
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kingsview Wealth Management, LLC holds $172,226,536 across 14 Drug Manufacturers - General names. LLY ranks #1 (57.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
82,083 | $98,452,820 | |
| 2 | JNJ |
Johnson & Johnson
|
94,143 | $23,909,497 | |
| 3 | ABBV |
AbbVie Inc.
|
71,689 | $18,039,819 | |
| 4 | MRK |
Merck & Co., Inc.
|
80,440 | $10,336,540 | |
| 5 | AMGN |
Amgen Inc
|
18,729 | $6,782,145 | |
| 6 | PFE |
Pfizer Inc
|
212,065 | $5,106,525 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
45,093 | $2,598,258 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
17,845 | $2,254,537 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $98,452,820 | 82,083 | Shares | Sole | 2026-08-19 | |
| 2026-03-31 | $69,415,961 | 75,471 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $75,875,639 | 70,603 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $63,630,385 | 83,395 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $56,347,546 | 72,284 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $57,355,319 | 69,445 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $49,288,340 | 63,845 | Shares | Defined | 2025-01-28 | |
| 2024-09-30 | $48,442,313 | 54,679 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $47,831,225 | 52,830 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $39,388,892 | 50,631 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $28,685,492 | 49,210 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $22,728,655 | 42,315 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $21,303,416 | 45,425 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $15,866,690 | 46,202 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $15,326,134 | 41,893 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $8,478,883 | 26,222 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $7,996,807 | 24,664 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $14,879,211 | 51,958 | Shares | Defined | 2024-02-08 | |
| 2021-12-31 | $3,875,366 | 14,030 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $3,103,694 | 13,433 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $5,002,158 | 21,794 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $3,409,651 | 18,251 | Shares | Defined | 2021-05-24 | |
| 2020-12-31 | $1,892,189 | 11,207 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $805,376 | 5,441 | Shares | Sole | 2020-11-19 | |
| 2020-09-30 | $15,802 | 400 | Call | Sole | 2020-11-19 | |
| 2020-06-30 | $713,033 | 4,343 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $746,591 | 5,382 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||